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Abstract
Background: Understanding where adults with diabetes in India are lost in the diabetes care cascade is essential for the
design of targeted health interventions and to monitor progress in health system performance for managing diabetes
over time. This study aimed to determine (i) the proportion of adults with diabetes in India who have reached each step
of the care cascade and (ii) the variation of these cascade indicators among states and socio-demographic groups.
Methods: We used data from a population-based household survey carried out in 2015 and 2016 among women and
men aged 15–49 years in all states of India. Diabetes was defined as a random blood glucose (RBG) ≥ 200mg/dL or
reporting to have diabetes. The care cascade—constructed among those with diabetes—consisted of the proportion
who (i) reported having diabetes (“aware”), (ii) had sought treatment (“treated”), and (iii) had sought treatment and had a
RBG < 200mg/dL (“controlled”). The care cascade was disaggregated by state, rural-urban location, age, sex, household
wealth quintile, education, and marital status.
Results: This analysis included 729,829 participants. Among those with diabetes (19,453 participants), 52.5% (95% CI, 50.6–
54.4%) were “aware”, 40.5% (95% CI, 38.6–42.3%) “treated”, and 24.8% (95% CI, 23.1–26.4%) “controlled”. Living in a rural
area, male sex, less household wealth, and lower education were associated with worse care cascade indicators. Adults
with untreated diabetes constituted the highest percentage of the adult population (irrespective of diabetes status) aged
15 to 49 years in Goa (4.2%; 95% CI, 3.2–5.2%) and Tamil Nadu (3.8%; 95% CI, 3.4–4.1%). The highest absolute number of
adults with untreated diabetes lived in Tamil Nadu (1,670,035; 95% CI, 1,519,130–1,812,278) and Uttar Pradesh (1,506,638;
95% CI, 1,419,466–1,589,832).
Conclusions: There are large losses to diabetes care at each step of the care cascade in India, with the greatest loss
occurring at the awareness stage. While health system performance for managing diabetes varies greatly among India’s
states, improvements are particularly needed for rural areas, those with less household wealth and education, and men.
Although such improvements will likely have the greatest benefits for population health in Goa and Tamil Nadu, large
states with a low diabetes prevalence but a high absolute number of adults with untreated diabetes, such as Uttar
Pradesh, should not be neglected.
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Introduction
India—home to over one sixth of the world’s population
[1]—is in the midst of a diabetes epidemic [2, 3]. In na-
tionally representative studies of India from 2012 to
2014, we recently reported a crude prevalence of dia-
betes of 7.5% (95% CI, 7.3–7.7%) [4], as well as a high
predicted cardiovascular disease (CVD) risk across all
population groups [5]. The United Nations (UN) mem-
ber states agreed to reduce premature mortality from
non-communicable diseases (NCDs) by one third by
2030 (Sustainable Development Goal [SDG] target 3.4),
and the World Health Organization (WHO) member
states to halt the rise of diabetes by 2025 [6, 7]. Failing
to meet these targets will result in high avoidable mor-
bidity and mortality and a substantial economic burden
from lost productivity and increased healthcare costs [8].
Strong health system performance for diabetes across
the care continuum—from screening and early detection
to timely treatment and long-term adherence—is essen-
tial to achieve glycemic control and prevent complica-
tions of diabetes [9, 10]. In addition to providing a
benchmark for future comparison, understanding the
current state of health system performance for diabetes
in India could directly inform the design of targeted in-
terventions and programs that give patients the best
chance of achieving good glycemic control. A useful ap-
proach to studying health system performance in man-
aging chronic diseases is the cascade of care. Initially
conceptualized to monitor human immunodeficiency
virus (HIV) program effectiveness [11], and then to
examine achievement of global HIV care goals [12], the
care cascade approach has recently been applied to
examine the management of diabetes in Malawi [13],
South Africa [14], and the USA [15]. The care cascade is
based on the idea that those with a particular chronic
condition transition across a number of care steps (e.g.,
screening, diagnosis, and initiation of treatment) before
they can achieve successful “control” of the condition.
Apart from its simplicity and relation to the care process
in a program, and hence interpretability by policy
makers and practitioners, a key advantage of this ap-
proach is that it clearly depicts along which steps pa-
tients are “lost” to management across the care
continuum in a health system.
While we have examined health system performance for
the management of diabetes in 12 countries in sub-Saharan
Africa [16], no such study exists for India. The Indian
Council of Medical Research—India Diabetes (ICMR-IN-
DIAB) study provided estimates of diabetes awareness
among 57,000 adults in 14 of 29 states and one of seven
Union Territories of India and glycemic control estimates
among a smaller subset of 14,200 adults [17, 18]. This
study, however, is the first to use large-scale population--
based data from all states and Union Territories to
comprehensively assess health system performance for dia-
betes in India and its variation among states. Specifically,
analyzing data from 730,000 adults with a random plasma
glucose measurement, we aimed to assess (i) the proportion
of adults with diabetes in India who have reached each step
of the diabetes care cascade (awareness of diagnosis, sought
treatment, and—with some important limitations—gly-
cemic control) and (ii) the variation of these care cascade
indicators among states and socio-demographic groups
across the country.
Methods
Data source
We used data from the fourth National Family Health
Survey (NFHS-4), which was carried out between 2015
and 2016 and covered all districts (using district delinea-
tions from the time of the 2011 India census) [19] in the
29 states and seven Union Territories (henceforth also re-
ferred to as “states”) of India. Within each district, the
sampling process was carried out differently in rural than
in urban areas. In rural areas, villages were used as pri-
mary sampling units (PSUs), which were selected with
probability proportional to size, while census enumeration
blocks—selected through simple random sampling—were
used as PSUs in urban areas. Twenty-two households in
each PSU were selected through systematic random sam-
pling after a complete mapping and household listing in
the selected PSUs. Within all selected households, all
non-pregnant women aged 15–49 years who had stayed in
the household the night prior to the survey (including
both usual residents and visitors) were eligible for the sur-
vey questionnaire and a capillary blood glucose measure-
ment. Men aged 15–54 years in a household were only
eligible in a random subsample of 15% of households. We
excluded men aged 50–54 years from this survey to have
consistent age ranges among men and women. The re-
sponse rate among eligible women and men was 96.7%
and 91.9%, respectively. More details about the method-
ology of the NFHS-4 can be found in Additional file 1:
Methods S1.
Ethics
This analysis of an existing data set in the public domain
received a determination of “not human subjects re-
search” by the institutional review board of the Harvard
T. H. Chan School of Public Health on 9 May 2018.
Ascertaining diabetes
All participants were requested to undergo a one-time ca-
pillary blood glucose measurement using a handheld blood
glucometer (FreeStyle Optium H, manufactured by Abbott
Laboratories). Whole blood glucose measures were con-
verted into plasma-equivalent blood glucose by multiplying
with 1.11 [20]. Fasting was defined as reporting to have
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neither eaten nor drunk anything besides water for at least
12 h. Participants were not instructed to fast prior to the
blood glucose measurement. Only 1.1% of participants re-
ported to be fasted at the time of the measurement. Indi-
viduals with missing information on whether or not they
had fasted (0.3% of participants after excluding individuals
with a missing blood glucose measurement) were excluded
from this analysis. Diabetes was defined as having
responded with “yes” to the question “Do you currently
have diabetes?” or having a high plasma-equivalent blood
glucose reading (≥ 200mg/dL [11.1mmol/L] if participants
reported not to have fasted or ≥ 126mg/dL [7.0mmol/L] if
participants reported to be fasted).
Ascertaining the diabetes care cascade
The diabetes care cascade was constructed among only
those who had diabetes as per the definition above.
“Aware” was defined as having responded with “yes” to
the question “Do you currently have diabetes?” Only those
who were “aware” were asked whether they had sought
treatment. “Treated” was defined as having responded
with “yes” to the question “Have you sought treatment for
this issue [diabetes]?” Due to a lack of glycated
hemoglobin A1c data (HbA1c), “controlled” was defined
as being “treated” and having a plasma-equivalent blood
glucose below the threshold for diabetes used in this study
(< 200mg/dL if not fasted and < 126mg/dL if fasted).
Among urban African-Americans in the USA, this thresh-
old was found to have a positive predictive value for a
HbA1c > 8.0% of between 80 and 85% [21]. While treat-
ment guidelines generally consider a lower HbA1c cutoff
to indicate good glycemic control [22], we chose this
somewhat higher threshold to obtain a more conservative
measure of being “uncontrolled.” The rationale for prefer-
ring a conservative measure is that policy makers may
only want to endeavor to improve health system perform-
ance for diabetes if they can be reasonably certain that the
system’s performance is insufficient. We thus favored mis-
classifying an “uncontrolled” individual as being “con-
trolled” rather than the reverse. The outcomes “unaware,”
“untreated,” and “uncontrolled” were defined as the recip-
rocal values of “aware,” “treated,” and “controlled” among
those who had diabetes. The calculation of state popula-
tion estimates of these unmet needs for care variables is
described in Additional file 1: Methods S2.
Socio-demographic variables
The socio-demographic variables used as independent vari-
ables in this analysis were state, household wealth index
quintile, educational attainment, marital status (currently
married or not), and whether the household was located in
a rural or urban area. The household wealth index was cre-
ated based on a principal component analysis of binary var-
iables indicating household characteristics and household
ownership of durable goods as described in more detail in
Additional file 1: Methods S3. Education was categorized as
“Primary school or less,” “Secondary school unfinished,”
and “Secondary school or above.” The category “Primary
school or less” includes individuals without any formal edu-
cation, individuals who went to primary school but did not
finish, and individuals who completed primary school.
Statistical analysis
We constructed the diabetes care cascade for the national
sample (total, by sex, and rural versus urban areas) and dis-
aggregated by state using sampling weights to account for
the survey design. The sampling weights were also adjusted
for the higher probability of sampling women than men.
To investigate the association between diabetes prevalence
and care cascade indicators (i.e., the proportion of those
with diabetes who reached each step of the care cascade) in
a state/district, we plotted diabetes prevalence against
the care cascade indicator for each state and each district.
Lastly, we used covariate-adjusted logistic regression
models to investigate the association of care cascade indica-
tors with individual-level socio-demographic characteristics.
These regressions included a binary indicator (“fixed effect”)
for each of 640 districts to filter out effects associated with
the participants’ district on the outcomes. We used restricted
cubic splines with five knots for age in all regressions to
avoid loss of information due to categorization of this con-
tinuous variable. The knots were placed at the 5th, 27.5th,
50th, 72.5th, and 95th percentiles of the age distribution.
Socio-demographic information was available on
749,119 participants (647,451 women and 101,668 men)
when excluding pregnant women. 2.6% (19,290/749,119)
of all participants had a missing blood glucose measure-
ment or missing information on whether or not they had
fasted and were thus excluded, resulting in a sample of
729,829 participants (631,825 women and 98,004 men) for
analysis. All analyses were complete case analyses. Statis-
tical analyses were performed in R version 3.3.2.
Results
Sample characteristics
Individuals with a missing blood glucose measurement or
fasting status—2.6% (19,290/749,119) of all participants
with socio-demographic information—were more likely to
live in an urban area, have a higher educational attainment,
live in a wealthier household, and be men than those with
non-missing values (Additional file 1: Table S1). Table 1
shows the (unweighted) characteristics of the included par-
ticipants. 49.5% of participants were younger than 30 years,
40.3% went to secondary school but did not complete sec-
ondary school, 68.7% were married, and 29.5% lived in
urban areas. 2.7% of the participants had diabetes. There
were no missing values for age, education, household
wealth index, marital status, or urban area.
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Diabetes care cascade at the national level
The weighted prevalence of diabetes in the age group 15–
49 years was 3.3% (95% CI, 3.2–3.4%), with a prevalence of
3.0% (95% CI, 2.9–3.1%) among women and 3.6% (95%
CI, 3.3–3.8%) among men. Diabetes prevalence ranged
from 0.6% (95% CI, 0.5–0.7%) among women aged 15 to
19 years to 9.6% (95% CI, 8.7–10.5%) among men aged
45–49 years (Additional file 1: Table S2).
52.5% (95% CI, 50.6–54.4%) of those with diabetes
were aware of their condition, 40.5% (95% CI, 38.6–
42.3%) had sought treatment, and 24.8% (95% CI, 23.1–
26.4%) were “controlled” (Fig. 1). Men and participants
living in rural areas had worse outcomes for all diabetes
care indicators (except for diabetes control for rural ver-
sus urban areas) than women and those living in urban
areas. Care cascade indicators by 5-year age groups are
shown in Additional file 1: Table S3.
Diabetes care cascade by state
Among states (excluding Union Territories), diabetes
prevalence in the age group 15–49 years ranged from
1.6% (95% CI, 1.4–1.9%) in Rajasthan to 7.3% (95% CI,
5.4–9.7%) in Goa (Additional file 1: Table S4) and was
generally highest in South India (Additional file 1: Figure
S1). As shown in Fig. 2 and Additional file 1: Table
S5-S7, the prevalence of being aware of one’s diabetes
diagnosis ranged from 25.3% (95% CI, 19.4–32.3%)
among those with diabetes in Chhattisgarh to 69.6%
(95% CI, 52.6–82.6%) in Meghalaya. Among those with
diabetes, having sought treatment varied from 19.7%
(95% CI, 14.8–25.8%) in Chhattisgarh to 60.9% (95% CI,
45.1–74.8%) in Meghalaya, and the prevalence of con-
trolled diabetes ranged from 13.0% (95% CI, 7.9–20.6%)
in Nagaland to 53.7% (95% CI, 38.5–68.2%) in Megha-
laya. There was a tendency for districts and states with a
higher diabetes prevalence to have better care cascade
indicators (Fig. 3 and Additional file 1: Figure S3).
The percentage of the total population in a state who
had diabetes but was both unaware and untreated
ranged from 0.8% (95% CI, 0.7–0.9%) in Rajasthan to
4.0% (95% CI, 3.0–5.0%) in Goa (Additional file 1: Table
S8). The absolute number of adults with diabetes who
Table 1 Sample characteristics
Characteristic Total Female Male
No. 729,829 631,825 98,004
Diabetes, no. (%) 19,453 (2.7) 16,260 (2.6) 3193 (3.3)
Fasted, no. (%) 8317 (1.1) 7242 (1.1) 1075 (1.1)
Age group, no. in years (%)
15–19 131,984 (18.1) 113,974 (18.0) 18,010 (18.4)
20–24 116,099 (15.9) 100,551 (15.9) 15,548 (15.9)
25–29 113,300 (15.5) 98,131 (15.5) 15,169 (15.5)
30–34 102,670 (14.1) 88,818 (14.1) 13,852 (14.1)
35–39 99,206 (13.6) 85,959 (13.6) 13,247 (13.5)
40–44 85,412 (11.7) 73,966 (11.7) 11,446 (11.7)
45–49 81,158 (11.1) 70,426 (11.1) 10,732 (11.0)
Education, no. (%)
Primary school or less 285,263 (39.1) 261,104 (41.3) 24,159 (24.7)
Secondary school unfinished 293,994 (40.3) 247,058 (39.1) 46,936 (47.9)
Secondary school finished or above 150,572 (20.6) 123,663 (19.6) 26,909 (27.5)
Household wealth index quintile, no. (%)
Q1 (least wealthy) 134,810 (18.5) 117,732 (18.6) 17,078 (17.4)
Q2 145,106 (19.9) 125,974 (19.9) 19,132 (19.5)
Q3 150,502 (20.6) 130,348 (20.6) 20,154 (20.6)
Q4 148,048 (20.3) 127,521 (20.2) 20,527 (20.9)
Q5 (most wealthy) 151,363 (20.7) 130,250 (20.6) 21,113 (21.5)
Currently married, no. (%) 501,079 (68.7) 441,972 (70.0) 59,107 (60.3)
Urban area, no. (%) 215,231 (29.5) 184,532 (29.2) 30,699 (31.3)
These numbers were not weighted using sampling weights and represent all participants who had a non-missing value for the blood glucose measurement and
fasting variable. Sample characteristics stratified by whether the blood glucose measurement or fasting status was missing are shown in Additional file 1: Table S1.
The education group “Primary school or less” includes individuals without formal education, individuals who went to primary school but did not finish, and
individuals who completed primary school
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was both unaware and untreated was highest in West
Bengal (1,284,631; 95% CI, 1,119,388–1,442,204), Uttar
Pradesh (1,225,532; 95% CI, 1,136,322–1,314,045), and
Tamil Nadu (1,039,484; 95% CI, 888,052–1,199,337)
(Additional file 1: Table S9).
Diabetes care indicators by individuals’ socio-
demographic characteristics
Covariate-adjusted logistic regressions of diabetes care in-
dicators on individual’s socio-demographic characteristics
(Table 2) show that being female, educational attainment,
and a higher household wealth quintile were generally
positively associated with better diabetes care indicators in
both rural and urban areas. Being currently married was
positively associated with each diabetes care cascade indi-
cator in urban areas but negatively (except for the “con-
trolled” step for which there was no association) in rural
areas. Older age was more strongly associated with reach-
ing each cascade step in urban than in rural areas, with
the most positive association existing for the treatment
step (Fig. 4). Additional file 1: Figure S4 shows that both
the absolute and relative differences between household
wealth index quintiles in the probabilities of being aware
of one’s diabetes and having sought treatment increased
with age group.th=tlb=
Discussion
Using data from 729,829 individuals aged 15–49 years in
India, we found that 3.3% (95% CI, 3.2–3.4%) had dia-
betes, of whom 52.5% (95% CI, 50.6–54.4%) were aware
of their condition, 40.5% (95% CI, 38.6–42.3%) had
sought treatment, and 24.8% (95% CI, 23.1–26.4%) had
sought treatment and had a random plasma-equivalent
blood glucose below the threshold for diabetes (“con-
trolled”). Thus, across the care cascade from “aware” to
“control,” a total of 75% of participants with diabetes
were “lost” to care, 47% at the awareness stage, 12% at
the treatment stage, and 16% due to failure to achieve
control despite having sought treatment.
Hence, while in the Indian health system a substantial
proportion of patients are lost to care at each step of the
diabetes care cascade, there appears to be a particularly
Fig. 1 The cascade of care for diabetes in India. A flowchart of the cascade of care can be found in Additional file 1: Figure S5. Nineteen thousand
four hundred fifty-three individuals with diabetes were included in this figure; 10,504 were “aware”, 8269 “treated”, and 5329 “controlled”
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Fig. 2 State-level variation in diabetes awareness, treatment, and control. Estimates with 95% confidence intervals are shown in Additional file 1:
Table S10-S12. Diabetes prevalence estimates by sex and state are shown in Additional file 1: Table S13. Nineteen thousand four hundred fifty-
three individuals with diabetes were included in this figure; 10,504 were “aware,” 8269 “treated,” and 5329 “controlled”
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high need for improved detection of diabetes. Several
large-scale efforts to improve diabetes screening in India
have recently begun, such as the 5-year “UDAY” pro-
gram in the states of Andhra Pradesh and Haryana [24].
Even though improved detection of diabetes cases seems
essential, we would like to note that, thus far, no study
in high-income countries has shown that screening
alone improves diabetes-related outcomes [25]. In
addition, a crucial question for the success of large-scale
diabetes screening programs in India will be whether the
health system is able to effectively cope with the result-
ing increase in demand for diabetes care.
We also identified important variation in the care cas-
cade among population groups with indicators being
worse for rural areas, men, those with less education,
and—particularly among older age groups—those with
lower household wealth. It is possible that some of the
better health system performance for diabetes among
women than men is explained by routine screening for
gestational diabetes during antenatal care. The relatively
low health system performance for diabetes among the
rural poor is concerning from a health equity perspective
given that these individuals (i) likely have the lowest ac-
cess to high-quality care for the micro- and macrovascu-
lar complications of diabetes, (ii) are most likely to
experience catastrophic healthcare expenditures from
these complications [26, 27], and (iii) are most reliant on
their physical health to earn their livelihood given that
many of these individuals are subsistence farmers [28].
In addition to a focus on men, interventions to improve
health system performance for diabetes are, therefore,
particularly needed among rural populations with little
education and household wealth.
The diabetes care cascade varied widely among states
in India, with states with a lower prevalence of diabetes
tending to have poorer diabetes care indicators, possibly
because many of these—often less wealthy—states’
health systems largely focus on communicable diseases
and maternal and child health [29], which still cause an
important disease burden in India [30]. Nonetheless,
given their population size, these states frequently have a
large number of adults with diabetes. For example, Uttar
Pradesh—a state with one of the lowest prevalence levels
of diabetes in India—had one of the largest absolute
numbers of adults who were unaware of their diabetes
diagnosis (1,225,532; 95% CI, 1,136,322–1,314,045).
While diabetes may not be a public health priority for
these states, improvements in diabetes care are still es-
sential in these states to increase health system perform-
ance for diabetes in India at the national level. As a
percentage of the total adult population aged 15–49
years, the states and Union Territories with the highest
proportion of adults who had diabetes but had never
sought diabetes treatment were Goa (4.2%; 95% CI, 3.2–
5.2%), Tamil Nadu (3.8%; 95% CI, 3.4–4.1%), and Anda-
man and Nicobar Islands (3.7%; 95% CI, 2.7–4.8%), dem-
onstrating a particularly high need to intensify diabetes
detection and care programs in these states.
To our knowledge, only three other studies—from
Malawi [13], South Africa [14], and the USA [15]—have
assessed the diabetes care cascade in a nationwide sample.
While these studies differed in their definition of individual
cascade steps, the proportion of adults with diabetes who
were aware of their diagnosis was substantially lower in
India (52.5% [95% CI, 50.6–54.4%]) than in the USA
(72.2%), but comparable to that found in South Africa
(45.4%) and Malawi (41.2%). Comparing our results to the
ICMR-INDIAB study, which has published relevant data on
14 of 29 states and one of seven Union Territories in India,
we find that our estimate of being aware of one’s diabetes
diagnosis was very similar (52.7% in ICMR-INDIAB versus
52.5% [95% CI, 50.6–54.4%] in this analysis) [18, 31, 32]. As
in this study, ICMR-INDIAB found awareness of one’s dia-
betes diagnosis to be lower in rural than in urban areas
Fig. 3 The association between district-level diabetes prevalence and care cascade indicators. All estimates were age-standardized to the Global
Burden of Disease Project’s age structure for India for 2015 [23]. The same figure drawn separately for the age groups 15–29 years, 30–39 years,
and 40–49 years can be found in Additional file 1: Figure S2. P values indicate the statistical significance of the slope of the regression line shown
in black, which is an ordinary least squares regression of district-level diabetes prevalence onto district-level awareness/treatment among those
with diabetes. R2 values are from the same regression. Nineteen thousand four hundred fifty-three individuals with diabetes were included in this
figure; 10,504 were “aware”, 8269 “treated”, and 5329 “controlled”
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(with a ratio of self-reported diabetes to newly diagnosed
diabetes in rural areas of 1:1.5 compared to 1:0.7 in urban
areas) [18]. Glycemic control estimates obtained from a
subsample of 14,200 adults with diabetes in ICMR-INDIAB
were somewhat higher than those in this study (31% in
ICMR-INDIAB versus 24.8% [95% CI, 23.1–26.4%] in our
analysis) [17], likely at least partially due to the fact that
ICMR-INDIAB was able to assess glycemic control using a
HbA1c measurement while we had to rely on random
blood glucose.
This analysis has highlighted the great potential for im-
proving diabetes control among adults aged 15–49 years with
diabetes in India. An additional—and possibly more
cost-effective—strategy to reducing the impact of diabetes on
population health in India is primary prevention efforts. The
reasons for the rapid rise of diabetes in the Indian population
are not entirely understood but likely include (i) population
aging [1], (ii) change of lifestyles from manual labor to seden-
tary work environments for an increasing proportion of In-
dians [33, 34], (iii) lack of green space for physical exercise in
many urban areas [35], and (iv) changing dietary patterns
[33, 36]. Further factors that have been linked to diabetes
and appear particularly pertinent to India include air pollu-
tion [37, 38], low birth weight (which is comparatively preva-
lent in India) [39–42], and a genetic predisposition towards
developing diabetes among South Asians [43–46]. While re-
forms and interventions to improve health services for dia-
betes in India will be important, we believe that a successful
response to India’s diabetes epidemic should also include ef-
forts to address some of these underlying reasons for the rise
of diabetes in the population. Such efforts may include infor-
mation campaigns, changes in the physical environment to
improve opportunities for physical exercise, innovations in
the transport system and regulatory reform to curb air pollu-
tion, and interventions to improve the availability and afford-
ability of healthy foods.
This study has several limitations. First, for the vast major-
ity of participants (98.9%), diabetes was defined based on a
random blood glucose measurement. According to the Inter-
national Diabetes Federation, a random blood glucose meas-
urement ≥ 200mg/dL would have to be measured in a
symptomatic patient in order to be considered as a
diabetes-defining criterion [22]. We, however, had no data
on diabetes symptoms. Given that the random blood glucose
measurement likely misclassified a substantial number of
adults without diabetes as having diabetes (and that we
would not expect those without diabetes to have previously
been told to have diabetes or to be on treatment), this imper-
fect measurement of diabetes probably biased the care cas-
cade indicators downwards. Second, glycemic control should
ideally be assessed with an HbA1c measurement rather than
a random blood glucose measurement. Apart from adding
noise to our “controlled” estimates and thus resulting in less
precise regression estimates for that cascade step, it is un-
clear whether and how this limitation biased our results.
Third, treatment of diabetes was ascertained through the
question “Have you sought treatment for this issue [dia-
betes]?” which did not allow us to assess what (if any) treat-
ment was prescribed (e.g., oral medications, insulin, and/or
advice to change lifestyle behaviors) and whether the partici-
pant was still taking the treatment at the time of the survey.
This limitation highlights the need to improve questionnaire
design for large-scale government-led studies in India. To
aid comparison over time and across countries, it would also
be useful for future assessments of cardiometabolic disease
care to use a standardized set of questions. Fourth, eligibility
Fig. 4 The predicted probability of reaching each cascade step by age as a continuous variable. Predicted probabilities were average adjusted
predictions obtained from covariate-adjusted logistic regressions of diabetes care indicators on individuals’ socio-demographic characteristics
(age, household wealth quintile, education, marital status, sex) and district-level fixed effects. We used restricted cubic splines with five knots for
the continuous variable age. The knots were placed at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Nineteen thousand four hundred fifty-
three individuals with diabetes were included in this figure; 10,504 were “aware”, 8269 “treated”, and 5329 “controlled”
Prenissl et al. BMC Medicine           (2019) 17:92 Page 9 of 12
for this survey was restricted to those aged 15–49 years,
which implies that our estimates of diabetes prevalence and
care cascade indicators are not representative for the entire
adult population. It is likely that this age restriction, along
with the use of a random instead of a fasting plasma glucose,
largely explains the lower prevalence of diabetes in this study
compared to that in a recently published older sample of the
Indian population [4], as well as the IMCR-INDIAB study
[18]. Fifth, we were not able to differentiate between type 1
and type 2 diabetes in this study. However, it is very likely
that the vast majority of those with diabetes in this analysis
had type 2 diabetes. According to the International Diabetes
Federation, an estimated 72,000 children aged 0 to 14 years
lived with type 1 diabetes in India in 2015, which corre-
sponds to just 0.02% of the country’s population in this age
range [2, 47]. Lastly, men were underrepresented in this ana-
lysis, constituting only 13.4% of the total sample. However,
the sample still contains a large absolute number of men
(98,004), thus allowing for reasonably precise estimates of
diabetes prevalence and care for men. We corrected for the
lower probability of selecting men in this survey through
weighting. In addition, we show all results (either in the main
manuscript or in the appendix) disaggregated by sex.
Conclusions
This large population-based analysis of adults aged 15–49
years found substantial losses of patients at each step of
the diabetes care cascade, with the highest proportion
(47%) being lost to care at the awareness stage. Improve-
ments in health system performance for diabetes in India
are particularly needed for rural areas, those with little
wealth and education, and men. While adults with undiag-
nosed diabetes make up the largest proportion of the
state’s population in Goa and Andhra Pradesh, efforts at
improving diabetes care should not neglect large states
with a low diabetes prevalence (e.g., Uttar Pradesh), which
host some of the highest absolute numbers of adults who
are unaware of their diabetes and untreated. India’s suc-
cess in coping with the consequences of its diabetes epi-
demic will in an important part depend on its ability to
improve health system performance for diabetes. “Sealing
the leaks” of the diabetes care cascade will thus be a cru-
cial determinant of the country’s ability to reach the SDG
target of reducing premature mortality from NCDs by one
third by 2030 [7]. Given the country’s size and projected
population growth, India’s performance in achieving this
target will ultimately also have a decisive influence on the
world’s ability to reach this SDG.
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